Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-FR Version v1-EN
Language French English
Date Updated 2017-03-10 2017-03-10
Drug Identification Number 02246895 02246895
Brand name APO-VERAP SR APO-VERAP SR
Common or Proper name VERAPAMIL SR VERAPAMIL SR
Company Name APOTEX INC APOTEX INC
Ingredients VERAPAMIL HYDROCHLORIDE VERAPAMIL HYDROCHLORIDE
Strength(s) 240MG 240MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100 BTL and 500 BTL 100 BTL and 500 BTL
ATC code C08DA C08DA
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2014-03-19 2014-03-19
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Company comments
Health Canada comments